|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:adjuvant
|
gptkb:AS03
|
|
gptkbp:approvalYear
|
2009
|
|
gptkbp:approvedBy
|
gptkb:European_Union
|
|
gptkbp:containsAdjuvantComponent
|
gptkb:polysorbate_80
gptkb:DL-α-tocopherol
gptkb:squalene
|
|
gptkbp:containsAntibiotic
|
gentamicin
|
|
gptkbp:containsAntigen
|
gptkb:H1N1_influenza_virus_antigen
|
|
gptkbp:containsDeoxycholate
|
trace amounts
|
|
gptkbp:containsEggProtein
|
yes
|
|
gptkbp:containsFormaldehyde
|
trace amounts
|
|
gptkbp:containsPreservative
|
thiomersal
|
|
gptkbp:containsStabilizer
|
gptkb:disodium_phosphate
gptkb:magnesium_chloride
sodium chloride
sucrose
potassium dihydrogen phosphate
water for injections
|
|
gptkbp:containsVirusStrain
|
gptkb:A/California/7/2009_(H1N1)
gptkb:A/California/7/2009_(H1N1)v-like_strain
gptkb:NYMC_X-179A
gptkb:X-179A_reassortant_virus
|
|
gptkbp:features
|
increased risk of narcolepsy in children and adolescents
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pandemrix
|
|
gptkbp:indication
|
influenza
|
|
gptkbp:manufacturer
|
GlaxoSmithKline
|
|
gptkbp:marketedAs
|
gptkb:GlaxoSmithKline_Biologicals
|
|
gptkbp:notRecommendedFor
|
children under 6 months
people with hypersensitivity to any component
people with severe egg allergy
|
|
gptkbp:regulates
|
gptkb:European_Medicines_Agency
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
narcolepsy
injection site reactions
|
|
gptkbp:status
|
no longer widely used
|
|
gptkbp:type
|
vaccine
|
|
gptkbp:usedDuring
|
gptkb:2009_H1N1_influenza_pandemic
|
|
gptkbp:withdrawn
|
several countries
|
|
gptkbp:bfsParent
|
gptkb:GSK
|
|
gptkbp:bfsLayer
|
6
|